(Upper Respiratory Infection; URI; Coryza)
About 50% of all colds are caused by one of the > 100 serotypes of rhinoviruses. Coronaviruses cause some outbreaks, and infections caused by influenza viruses, parainfluenza viruses, enteroviruses, adenoviruses, respiratory syncytial viruses, and metapneumoviruses may also manifest as the common cold, particularly in patients who are experiencing reinfection.
Rhinovirus infections are most common during fall and spring and are less common during winter.
Rhinoviruses are most efficiently spread by direct person-to-person contact, although spread may also occur via large-particle aerosols.
The most potent deterrent to infection is the presence of specific neutralizing antibodies in the serum and secretions, induced by previous exposure to the same or a closely related virus. Susceptibility to colds is not affected by exposure to cold temperature, host health and nutrition, or upper respiratory tract abnormalities (eg, enlarged tonsils or adenoids).
After an incubation period of 24 to 72 hours, cold symptoms begin with a scratchy or sore throat, followed by sneezing, rhinorrhea, nasal obstruction, and malaise. Temperature is usually normal, particularly when the pathogen is a rhinovirus or coronavirus. Nasal secretions are watery and profuse during the first days but then become more mucoid and purulent. Mucopurulent secretions do not indicate a bacterial superinfection. Cough is usually mild but often lasts into the 2nd week. Most symptoms due to uncomplicated colds resolve within 10 days.
Diagnosis of the common cold is generally made clinically and presumptively, without diagnostic tests, although polymerase chain reaction (PCR) testing is available in many multiplex platforms.
Allergic rhinitis is the most important consideration in differential diagnosis.
No specific treatment for the common cold exists.
Antipyretics and analgesics may relieve fever and sore throat.
Nasal decongestants may reduce nasal obstruction. Topical nasal decongestants are more effective than oral decongestants, but the use of topical drugs for > 3 to 5 days may result in rebound congestion.
Rhinorrhea may be relieved with 1st-generation antihistamines (eg, chlorpheniramine) or intranasal ipratropium bromide (2 sprays of a 0.03% solution 2 or 3 times a day); however, these drugs should be avoided in older patients and people with benign prostatic hypertrophy or glaucoma. First-generation antihistamines frequently cause sedation, but 2nd-generation (nonsedating) antihistamines are ineffective for treating the common cold.
Antihistamines and decongestants are not recommended for children < 4 years.
There are no vaccines for the common cold.
Polyvalent bacterial vaccines, citrus fruits, vitamins, ultraviolet light, glycol aerosols, and other folk remedies do not prevent the common cold. Handwashing and use of surface disinfectant in a contaminated environment may reduce spread of infection.
Antibiotics should not be given unless there is clear evidence of secondary bacterial infection. In patients with chronic lung disease, antibiotics may be given with less restriction.
Many viruses can cause the common cold; rhinoviruses cause about half of colds.
Susceptibility to colds is not affected by exposure to cold, host health and nutrition, or the presence of upper respiratory tract abnormalities.
Antihistamines may be used to relieve rhinorrhea, but they should not be used in older patients or children < 4 years.
Topical and oral decongestants relieve nasal obstruction, but repeated use may cause rebound congestion.
Many substances have been evaluated for prevention and treatment, but none has clearly been shown to be beneficial.
Drugs Mentioned In This Article
|Drug Name||Select Trade|